Funding

A relevant doctorate must be completed before the start; scholarship support is limited to two years within four years after the doctorate. Protein biochemistry and biophysics, cell and molecular methods, and lipid-mediator expertise are required.

Host approval and eligible university, medical research, nonprofit or public health employment are required.

Researchers of any nationality are eligible. Only work published in peer-reviewed journals is considered; self-nominations are excluded. Submit the nomination form, achievements statement, CV and major publications, with supporting letters where appropriate.

Mid-career researchers apply through an eligible Australian administering organisation. The PhD award date must fall between 1 March 2012 and 1 March 2022, or be equivalent after allowable career interruptions. A maximum of three applications is permitted. ARC medical-research exclusions apply.

The researcher must be a strategic recruitment priority for the host; applications are institutional rather than direct individual submissions.

Fellowship-trained cerebrovascular/endovascular specialists who are board certified, hold a CAST neuroendovascular certificate or demonstrate substantial open cerebrovascular practice, and have practised independently for at least five years. Applicants must be dues-paying members in good standing of the AANS/CNS Joint Cerebrovascular Section or SNIS. A suitable host invitation is required; the selection committee determines applicant and host eligibility. Only nonprofit charitable hosts, or for-profit hosts affiliated with a nonprofit, qualify.

Medical students in accredited U.S., Canadian or Mexican programmes who will have completed at least one year of medical school by the fellowship start. Caribbean medical schools with U.S. clinical campuses may be considered. PhD, MD/PhD, gap-year and post-baccalaureate students are ineligible. Applicants must identify an AANS-member neurosurgical investigator sponsor.

Research fellowship: physicians accepted into or currently enrolled in approved North American neurological-surgery residencies, with 80% research effort. Young clinician: neurosurgeons within two years of residency or clinical-fellowship completion, with full-time faculty appointments at North American teaching institutions and 50% research effort; exceptions may be considered. Applicants without a confirmed faculty position for the award period are encouraged to apply. Sponsor and institutional endorsement are required.

Relevant first degree and quantitative preparation; UCL admissions and English Level 3 requirements.

Undergraduate degree in a relevant field (neuroscience or other life sciences, physics, mathematics or computer science) and interest in neuroscience; offer holders must meet UCL's standard admissions and English language requirements.

Living scientists, physicians or researchers nominated by someone else; self-nomination is not accepted. Nominees cannot already have received a Nobel Prize for the same discovery. Multiple nominations from an institution are permitted.

Relevant first degree, strong mathematical/analytical preparation and interest in neuroscience or machine learning; UCL admission and Level 3 English requirements apply. At least two academic references.

UK project leads must be at UKRI-eligible organisations. Consortia need partners from at least three participating countries, including at least two EU member or Horizon Europe associated countries. UK funding covers topics 1–3; the participating-funder rules govern other partners.

UK applicants must be based at an organisation eligible for NERC funding and satisfy the joint call’s international consortium rules and national funding conditions. Consult the call documents before forming a consortium.

Project leads must be based at a UK research organisation eligible for UKRI funding and meet UKRI individual eligibility rules. Research technical professionals may apply as project lead or co-lead; international researchers may participate only through the specified cooperation agreements or as collaborators.

Eligible UK higher-education institutions, research-council institutes, approved independent research organisations, public-sector research establishments and NHS bodies with research capacity may lead. Businesses participate as partners. Postdoctoral fellowship holders cannot apply as lead. Each person may lead one proposal and appear on at most two. International co-lead exceptions follow the stated Norway and IIASA agreements.

Lead applicants must be based at an eligible UK research organisation and meet UKRI individual eligibility. Industry partners must shape the challenge and application, provide appropriate support and commit matching funds. The call concerns scaling newly developed technologies and processes, rather than inventing new products.

Single UK-registered micro, small or medium-sized enterprise; one application per SME. Subcontractors are not permitted. The core innovation must be novel AI or ML technology, starting at TRL 1–3, with technical validation and a credible route to defensibility and scale.

Applicants must be based at a research organisation eligible for Medical Research Council funding and propose a high-risk development step for a medical product that builds on prior funded work.